Authors:
Monforte, AD
Adorni, F
Meroni, L
Bini, T
Testa, L
Chiesa, E
Melzi, S
Rusconi, S
Sollima, S
Galli, M
Moroni, M
Citation: Ad. Monforte et al., Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimen, BIOMED PHAR, 55(1), 2001, pp. 16-22
Authors:
Bini, T
Testa, L
Chiesa, E
Adorni, F
Abeli, C
Castelnuovo, B
Melzi, S
Sollima, S
Bongiovanni, M
Monforte, AD
Citation: T. Bini et al., Outcome of a second-line protease inhibitor-containing regimen in patientsfailing or intolerant of a first highly active antiretroviral therapy, J ACQ IMM D, 24(2), 2000, pp. 115-122
Authors:
Chignola, R
Schenetti, A
Andrighetto, G
Chiesa, E
Foroni, R
Sartoris, S
Tridente, G
Liberati, D
Citation: R. Chignola et al., Forecasting the growth of multicell tumour spheroids: implications for thedynamic growth of solid tumours, CELL PROLIF, 33(4), 2000, pp. 219-229
Authors:
Lorenzetti, I
Meneguzzi, A
Fracasso, G
Potrich, C
Costantini, L
Chiesa, E
Legname, G
Menestrina, G
Tridente, G
Colombatti, M
Citation: I. Lorenzetti et al., Genetic grafting of membrane-acting peptides to the cytotoxin dianthin augments its ability to de-stabilize lipid bilayers and enhances its cytotoxicpotential as the component of transferrin-toxin conjugates, INT J CANC, 86(4), 2000, pp. 582-589
Authors:
Monforte, AD
Testori, V
Adorni, F
Castelnuovo, B
Bini, T
Testa, L
Moscatelli, G
Chiesa, E
Rusconi, S
Abeli, C
Sollima, S
Musicco, M
Meroni, L
Galli, M
Moroni, M
Citation: Ad. Monforte et al., CD4 cell counts at the third month of HAART may predict clinical failure, AIDS, 13(13), 1999, pp. 1669-1676